International Stem Cell Corp. (ISCO) CSO to Present at American Academy of Neurology Annual Meeting in Philadelphia
International Stem Cell Corp., a California-based biotechnology company focused on developing novel stem cell-based therapies and biomedical products, announced today that Dr. Ruslan Semechkin, ISCO's Chief Scientific Officer, will present data from its pre-clinical primate studies of Parkinson's disease at the 66th American Academy of Neurology Annual Meeting in Philadelphia. The meeting is scheduled for Tuesday, April 29, 2014, at 1:00 p.m. EST. The topic is ‘Movement Disorders’ and the Session title is ‘Parkinson's disease: Preclinical and Clinical Therapeutics.’ The American Academy of Neurology Annual Meeting is known to be the world's largest gathering of neurologists. The American Academy of…